Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Trial of YF476, a Gastrin Antagonist, in Patients With Type II Gastric Carcinoids Associated With Zollinger-Ellison Syndrome

NCT02454075 is registered in ClinicalTrials.gov with Trio Medicines Ltd. as lead sponsor.

NCT NCT02454075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02454075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Trial of YF476, a Gastrin Antagonist, in Patients With Type II Gastric Carcinoids Associated With Zollinger-Ellison Syndrome
Lead sponsor
Trio Medicines Ltd.
Phase
Phase 2
Overall status
Terminated
Start date
April 11, 2011
Completion date
June 22, 2012
Enrollment
3 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

zollinger-ellison syndrome